Hongye Sun is the CTO of WuXi NextCODE and the head of WuXi NextCODE China. He joined WuXi AppTech in July, 2011 from Life Tech setting up WuXi AppTec Genome Center to integrate genomics into drug discovery, clinical development and personalized medicine. He established the first CLIA certified and CAP accredited Next Generation Sequencing lab in China. In 2015 WuXi AppTec acquired NextCODE Health which is merged with the genome center forming WuXi NextCODE, the global digital genomics platform company. Before he joined WuXi, he had spent over 10 years at Life Tech at Bay area working on new sequencing technology development and managing a multi-disciplinary team including biophysicists, chemists, biochemists, nano-fabrification engineers, optical engineers, and software engineers to develop a real-time single molecule DNA sequencing technology. He also served as a leader to write whitepapers on DNA sequencing technology development from 1st to 4th generation for ABI executive teams. He did his post doctor fellowship at Chemistry and Chemical Biology Dept at Harvard University and University of Kansas and received his PhD at Peking University. He has been invited for chairing and speaking at many international precision medicine conferences.